Literature DB >> 21861435

[Chronic fungal infection, up-to-date].

Hiroshi Kakeya1, Yoshihumi Imamura, Taiga Miyazaki, Koichi Izumikawa, Yoshihiro Yamamoto, Takayoshi Tashiro, Shigeru Kohno.   

Abstract

Deep-seated mycosis usually occurred in severe immunocompromised patients and is sometimes fatal. Hence, chronic fungal infection occurred in the patients with mild to moderate immunocompromised status and persists for longer period. Biofilm formation is one of the factors related to persisting infection of Candida spp. Biofilm formation resists to the antifungals in catheter-related Candida infection and selection of appropriate antifungals will be an important key to achieve good outcome. Although azoles possessed excellent antifungal activity against planktonic Candida spp., they show lower activity against biofilm-formed Candida spp. Overexpression of efflux pump of Candida spp. is reported to be involved in lowered activity of azoles. Amphotericin B, liposomal amphotericin B, and micafungin however, are expected to have high antifungal activity against biofilm-formed Candida spp. Recently, Aspergillus is also reported to possess potential of forming biofilm. Biofilm formation of Aspergillus is considered to be related to pathogenesis of chronic pulmonary aspergillosis. General antifungals are not highly active to biofilm-formed Aspergillus as same as Candida, and only amphotericin B and its liposomal formulation are expected to be effective in vitro.

Entities:  

Mesh:

Year:  2011        PMID: 21861435     DOI: 10.11150/kansenshogakuzasshi.85.333

Source DB:  PubMed          Journal:  Kansenshogaku Zasshi        ISSN: 0387-5911


  3 in total

1.  Structure-activity relationship study of the plant-derived decapeptide OSIP108 inhibiting Candida albicans biofilm formation.

Authors:  Nicolas Delattin; Katrijn De Brucker; David J Craik; Olivier Cheneval; Barbara De Coninck; Bruno P A Cammue; Karin Thevissen
Journal:  Antimicrob Agents Chemother       Date:  2014-06-09       Impact factor: 5.191

2.  Otomycosis in a Rural Community Attending a Tertiary Care Hospital: Assessment of Risk Factors and Identification of Fungal and Bacterial Agents.

Authors:  Priti Agarwal; Leimapokpam Sumitra Devi
Journal:  J Clin Diagn Res       Date:  2017-06-01

3.  Effectiveness of 7.5 percent povidone iodine in comparison to 1 percent clotrimazole with lignocaine in the treatment of otomycosis.

Authors:  Ajay Philip; Regi Thomas; Anand Job; V Rajan Sundaresan; Shalini Anandan; Rita Ruby Albert
Journal:  ISRN Otolaryngol       Date:  2013-07-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.